Raloxifene reduces circulating levels of interleukin-7 and monocyte chemoattractant protein-1 in postmenopausal women

Atherosclerosis

Volumn 204, Issue 2, 2009, Pages 471-475

  Yasui, Toshiyuki ^a   Uemura, Hirokazu ^a   Hyodo, Sari ^b   Yamada, Masayo ^a   Yamamoto, Satoshi ^a   Maegawa, Masahiko ^a   Tsuchiya, Naoko ^c   Noguchi, Masamichi ^c   Yuzurihara, Mitsutoshi ^c   Kase, Yoshio ^c   Irahara, Minoru ^a  

^a Human Development and Health Science   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c Tsumura Central Research Institute   (Japan)

Author keywords

Interleukin 7; MCP 1; Raloxifene

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTRADIOL; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 7; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; RALOXIFENE;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; AGED; BIOLOGICAL MARKERS; CHEMOKINE CCL2; DOWN-REGULATION; E-SELECTIN; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-7; LIPIDS; MIDDLE AGED; POSTMENOPAUSE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 67349250747     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.09.014     Document Type: Article

References (38)

1. Kern P.A., Ranganathan S., Li C., Wood L., and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280 (2001) E745-E751
2. Tedgui A., and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86 (2006) 515-581
3. Lagathu C., Yvan-Charvet L., Bastard J.P., et al. Long-term treatment with interleukin-1 beta induces insulin resistance in murine and human adipocytes. Diabetologia 49 (2006) 2162-2173
4. Sartipy P., and Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 100 (2003) 7265-7270
5. Kim C.S., Park H.S., Kawada T., et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes 30 (2006) 1347-1355
6. Reape T.J., and Groot P.H. Chemokines and atherosclerosis. Atherosclerosis 147 (1999) 213-225
7. Maury E., Ehala-Aleksejev K., Guiot Y., et al. Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab 293 (2007) E656-E665
8. Barrett-Connor E., et al. Raloxifene and cardiovascular events in osteoporotic postmenopausal women. JAMA 287 (2002) 847-857
9. Takahashi K., Mori-Abe A., Takata K., et al. Raloxifene improves the ovariectomy-induced impairment in endothelium-dependent vasodilation. Menopause 14 (2007) 656-661
10. Colacurci N., Manzella D., Fornaro F., Carbonella M., and Paolisso G. Endothelial function and menopause: effects of raloxifene administration. J Clin Endocrinol Metab 88 (2003) 2135-2140
11. Griffiths K.A., Sader M.A., Skilton M.R., Harmer J.A., and Celermajer D.S. Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease. J Am Coll Cardiol 42 (2003) 698-704
12. Ceresini G., Marchini L., Rebecchi I., et al. Effects of raloxifene on carotid blood flow resistance and endothelium-dependent vasodilation in postmenopausal women. Atherosclerosis 167 (2003) 121-127
13. Barrett-Connor E., et al. Effects of raloxifne on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 355 (2006) 125-137
14. Colacurci N., Fornaro F., Cobellis L., et al. Raloxifene slows down the progression of intima-media thickness in postmenopausal women. Menopause 14 (2007) 879-884
15. Blum A., Schenke W.H., Hathaway L., et al. Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women. Am J Cardiol 86 (2000) 892-895
16. Walsh B.W., Cox D.A., Sashegyi A., et al. Role of tumor necrosis factor-α and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women. Am J Cardiol 88 (2001) 825-828
17. Gianni W., Ricci A., Gazzaniga P., et al. Raloxifene modulates interleukin-6 and tumor necrosis factor-α synthesis in vivo: results from a pilot clinical study. J Clin Endocrinol Metab 89 (2004) 6097-6099
18. Yasui T., Maegawa M., Tomita J., et al. Changes in serum cytokine concentrations during the menopausal transition. Maturitas 56 (2007) 396-403
19. Ligthart G.J., Corberand J.X., Fournier C., et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev 28 (1984) 47-55
20. Murase Y., Kobayashi J., Nohara A., et al. Raloxifene promotes adipocyte differentiation of 3T3-L1 cells. Eur J Pharmacol 538 (2006) 1-4
21. Dus D., Krawczenko A., Zalecki P., et al. IL-7 receptor is present on human microvascular endothelial cells. Immunol Lett 68 (2003) 163-168
22. Krishnaswamy G., Kelley J., Yerra L., Smith J.K., and Chi D.S. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res 19 (1999) 91-104
23. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88 (1991) 5252-5256
24. Seli E., Pehlivan T., Selam B., Garcia-Velasco J.A., and Arici A. Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells. Fertil Steril 77 (2002) 542-547
25. Takahashi K., Mizuarai S., Araki H., et al. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem 278 (2003) 46654-46660
26. Miyatani Y., Yasui T., Uemura H., et al. Associations of circulating adiponectin with estradiol and monocyte chemotactic protein-1 in postmenopausal women. Menopause 15 (2008) 536-541
27. Han K.H., Tangirala R.K., Green S.R., and Quehenberger O. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. Arterioscler Thromb Vas Biol 18 (1998) 1983-1991
28. Cushing S.D., Berliner J.A., Valente A.J., et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 87 (1990) 5134-5138
29. Rezaie-Majd A., Maca T., Bucek R.A., et al. Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 22 (2002) 1194-1199
30. Ozmen B., Kirmaz C., Aydin K., et al. Influence of the selective oestrogen receptor modulator (raloxifne hydrochloride) on IL-6, TNF-α. TGF-β1 and bone turnover markers in the treatment of postmenopausal osteoporosis. Eur Cytokine Netw 18 (2007) 148-153
31. Yasui T., Maegawa M., Tomita J., et al. Association of serum cytokine concentrations with psychological symptoms in midlife women. J Reprod ImmunoI 75 (2007) 56-62
32. Alesci S., Martinez P.E., Kelkar S., et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 90 (2005) 2522-2530
33. Judd A.M., Call G.B., Barney M., et al. Possible function of IL-6 and TNF as intraadrenal factors in the regulation of adrenal steroid secretion. Ann N Y Acad Sci 917 (2000) 628-637
34. Bruun J.M., Lihn A.S., Madan A.K., et al. Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am J Physiol Endocrinol Metab 286 (2004) E8-E13
35. Yasui T., Uemura H., Tomita J., et al. Association of interleukin-8 with hot flashes in premenopausal, perimenopausal, and postmenopausal women and bilateral oophorectomized women. J Clin Endocrinol Metab 91 (2006) 4805-4808
36. Baek K.H., Oh K.W., Lee W.Y., et al. Changes in the serum sex steroids. IL-7 and RANKL-OPG system after bone marrow transplantation: influences on bone and mineral metabolism. Bone 39 (2006) 1352-1360
37. Weitzmann M.N., Roggia C., Toraldo G., Weitzmann L., and Pacifici R. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J Clin Invest 110 (2002) 1643-1650
38. Cheung J., Mak Y.T., Papaioannuou S., et al. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear κB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effect of 17β-oestradiol and raloxifene. J Endocrinol 177 (2003) 423-433